Micro Emerging Active

BSX EKOS System Successful Intermediate-Risk PE Treatment Trial

New narrative with limited coverage — still forming.

Score
0.2
Velocity
▲ 0.0
Articles
3
Sources
2

Top Movers

TickerSectorChange
BSX
Health Care-7.4%

Sentiment Timeline

Sector Performance

Event Timeline

Apr 29, 2026
Polen Focus Growth Sold Its Stake in Boston Scientific (BSX) Over Competition … Neutral
Apr 19, 2026
Here’s What Piper Sandler Thinks About Boston Scientific Corp (BSX) Now Bullish
Mar 28, 2026
Boston Scientific HI-PEITHO Trial Shows EKOS System Superior In Acute Pulmonary Embolism … Neutral

Related Articles

Here’s What Piper Sandler Thinks About Boston Scientific Corp (BSX) Now

Yahoo Finance · Apr 19, 2026
Mixed

Boston Scientific HI-PEITHO Trial Shows EKOS System Superior In Acute Pulmonary Embolism Treatment

Nasdaq · Mar 28, 2026
Mixed

Timeline

First SeenMar 28, 2026
Last UpdatedMar 28, 2026